MEI Pharma: A $2 Biotech Concern With 9 Lives [Seeking Alpha]
MEI Pharma, Inc. (MEIP)
Last mei pharma, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.meipharma.com
Company Research
Source: Seeking Alpha
Summary Today, we take a look at a small oncology concern based in San Diego called MEI Pharma. The company has several 'shots on goal', strategic partnerships, and, recently, addressed its funding needs. Below, I provide a quick analysis on this small-cap company and if it may finally reward its long-suffering shareholders. Women and cats will do as they please, and men and dogs should relax and get used to the idea. I have had a few questions come up from followers around a $2 biotech stock called MEI Pharma ( MEIP Company Overview: MEI Pharma is a small oncology concern based in San Diego. It is focused on developing various therapies for the treatment of cancer. The stock trades at $2.20 a share and has a market capitalization of just north of $200 million. Pipeline: The company's pipeline consists of four clinical-stage candidates, including one candidate 'pracinostat' in combination with Vidaza is in an ongoing Phase 3 global registration trial. The target for this combination t
Show less
Read more
Impact Snapshot
Event Time:
MEIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEIP alerts
High impacting MEI Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
MEIP
News
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
MEIP
Earnings
- 5/9/24 - Beat
MEIP
Sec Filings
- 12/20/24 - Form ARS
- 12/20/24 - Form DEFA14A
- 12/20/24 - Form DEF
- MEIP's page on the SEC website